An Iranian-Armenian LDLR frameshift mutation causing familial hypercholesterolemia

Area of Science:

• Genetics
• Molecular Biology
• Cardiovascular Disease Research

Background:

• Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein (LDL) cholesterol.
• Mutations in the low density lipoprotein receptor (LDLR) gene are a primary cause of FH.
• Genetic diversity in ethnic populations can influence the identification of disease-causing mutations.

Purpose of the Study:

• To identify the genetic basis of familial hypercholesterolemia in an Iranian-Armenian family.
• To characterize a novel mutation in the LDLR gene.
• To understand the pathogenetic mechanism of the identified mutation.

Main Methods:

• Polymerase chain reaction single-strand conformation polymorphism (PCR-SSCP) analysis was employed to screen for mutations.
• Direct sequencing was used to confirm the identified mutation.
• Clinical features of affected individuals were assessed.

Main Results:

• A novel two-nucleotide deletion in exon 10 of the LDLR gene, designated FH Yrmeih, was identified.
• This deletion results in a translational frameshift, leading to a truncated LDLR protein with a premature stop codon.
• The mutation was detected in a father and son presenting with heterozygous FH.

Conclusions:

• FH Yrmeih is the first identified pathogenetic LDLR mutation in patients of Iranian-Armenian ancestry.
• This finding expands the spectrum of known LDLR mutations causing familial hypercholesterolemia.
• Genetic studies in diverse ethnic groups are crucial for comprehensive understanding of FH.